Related Experiment Videos
Peptide vaccination using nonionic block copolymers induces protective anti-viral CTL responses
J G Lanier1, M J Newman, E M Lee
1Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, G211 Rollins Research Center, Atlanta, GA 30322, USA.
Vaccine
|October 16, 1999
Summary
High molecular weight nonionic block copolymers effectively enhance peptide vaccines, stimulating robust CD8(+) T cell responses against viral antigens. These novel adjuvants provide lasting immunity and protection against persistent viral infections.
Area of Science:
- Immunology
- Vaccinology
- Materials Science
Background:
- Nonionic block copolymers are emerging as potential vaccine adjuvants.
- Effective vaccine formulations are crucial for eliciting robust T cell responses.
Purpose of the Study:
- To evaluate high molecular weight nonionic block copolymers as adjuvants in peptide-based vaccines.
- To assess the capacity of these copolymer formulations to induce anti-viral CD8(+) T cell responses.
Main Methods:
- Water-in-oil and multiple emulsion formulations were prepared using a synthetic peptide antigen (LCMV NP118-126).
- Vaccines were administered to BALB/c ByJ mice (H-2d).
- CD8(+) T cell responses, including cytotoxic T lymphocyte (CTL) activity and IFN-gamma secretion, were measured.
Main Results:
- Copolymer formulations induced significant NP118-126 specific CTL and IFN-gamma secreting CD8(+) T cells.
- These responses were maintained for at least 90 days post-immunization.
- Prophylactic vaccination with the multiple emulsion formulation accelerated viral clearance and prevented persistent lymphocytic choriomeningitis virus (LCMV) infection.
Conclusions:
- High molecular weight nonionic block copolymers are effective adjuvants for peptide vaccines.
- These formulations induce durable, virus-specific CD8(+) T cell immunity.
- Copolymer-based vaccines offer protection against persistent viral infections.